טוען...
Heme-regulated eIF2α kinase in erythropoiesis and hemoglobinopathies
As essential components of hemoglobin, iron and heme play central roles in terminal erythropoiesis. The impairment of this process in iron/heme deficiency results in microcytic hypochromic anemia, the most prevalent anemia globally. Heme-regulated eIF2α kinase, also known as heme-regulated inhibitor...
שמור ב:
| הוצא לאור ב: | Blood |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Hematology
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6856985/ https://ncbi.nlm.nih.gov/pubmed/31554636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019001915 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|